NO20050073L - Ring-substituted diphenyllazetidinones, their preparation, their use, and drugs containing the compounds - Google Patents

Ring-substituted diphenyllazetidinones, their preparation, their use, and drugs containing the compounds

Info

Publication number
NO20050073L
NO20050073L NO20050073A NO20050073A NO20050073L NO 20050073 L NO20050073 L NO 20050073L NO 20050073 A NO20050073 A NO 20050073A NO 20050073 A NO20050073 A NO 20050073A NO 20050073 L NO20050073 L NO 20050073L
Authority
NO
Norway
Prior art keywords
compounds
preparation
substituted
ring
diphenyllazetidinones
Prior art date
Application number
NO20050073A
Other languages
Norwegian (no)
Inventor
Heiner Glombik
Hubert Heuer
Werner Kramer
Wendelin Frick
Hans-Ludwig Schaefer
Andreas Lindenschmidt
Gerhard Jaehne
Stefanie Flohr
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20050073L publication Critical patent/NO20050073L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives ringsubstituerte difenylazetidinoner med formel 1, en fremgangsmåte for fremstilling derav, medikamenter inneholdende forbindelsene samt forbindelsenes anvendelse for behandling av hyperlipidemi, arteriosklerose og hyperkolesterolemi.There are disclosed ring-substituted diphenylazetidinones of formula 1, a process for their preparation, medicaments containing the compounds, and the use of the compounds for the treatment of hyperlipidemia, arteriosclerosis and hypercholesterolemia.

NO20050073A 2002-06-19 2005-01-06 Ring-substituted diphenyllazetidinones, their preparation, their use, and drugs containing the compounds NO20050073L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10227506A DE10227506A1 (en) 2002-06-19 2002-06-19 Ring-substituted diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
PCT/EP2003/005815 WO2004000804A1 (en) 2002-06-19 2003-06-04 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof

Publications (1)

Publication Number Publication Date
NO20050073L true NO20050073L (en) 2005-01-06

Family

ID=29719281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050073A NO20050073L (en) 2002-06-19 2005-01-06 Ring-substituted diphenyllazetidinones, their preparation, their use, and drugs containing the compounds

Country Status (30)

Country Link
EP (1) EP1517892B1 (en)
JP (1) JP2005533072A (en)
CN (1) CN1662493A (en)
AR (1) AR039689A1 (en)
AT (1) ATE478842T1 (en)
AU (1) AU2003242616B2 (en)
BR (1) BR0311940A (en)
CA (1) CA2490109A1 (en)
DE (2) DE10227506A1 (en)
EC (1) ECSP045498A (en)
HN (1) HN2003000183A (en)
HR (1) HRP20041203A2 (en)
IL (1) IL165791A0 (en)
MA (1) MA27252A1 (en)
MX (1) MXPA04012236A (en)
MY (1) MY135850A (en)
NO (1) NO20050073L (en)
NZ (1) NZ537304A (en)
OA (1) OA12868A (en)
PA (1) PA8576001A1 (en)
PE (1) PE20040577A1 (en)
PL (1) PL372690A1 (en)
RS (1) RS108504A (en)
RU (1) RU2315754C2 (en)
SV (1) SV2004001549A (en)
TN (1) TNSN04255A1 (en)
TW (1) TW200404774A (en)
UY (1) UY27851A1 (en)
WO (1) WO2004000804A1 (en)
ZA (1) ZA200409381B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7447226B2 (en) * 2003-10-31 2008-11-04 International Business Machines Corporation Methods and apparatus for continuous connectivity between mobile device and network using dynamic connection spreading
WO2005061452A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
CA2589483C (en) 2004-12-03 2013-10-29 Schering Corporation Substituted piperazines as cb1 antagonists
US8361999B2 (en) 2005-04-04 2013-01-29 Pontificia Universidad Catolica De Chile Methods of treating cholesterol gallstone disease with ezetimibe
AU2006262441A1 (en) 2005-06-20 2007-01-04 Schering Corporation Piperidine derivatives useful as histamine H3 antagonists
SA06270191B1 (en) 2005-06-22 2010-03-29 استرازينيكا ايه بي Novel 2-Azetidinone Derivatives as Cholesterol Absorption Inhibitors for the Treatment of Hyperlipidaemic Conditions
AR060623A1 (en) 2006-04-27 2008-07-02 Astrazeneca Ab COMPOUNDS DERIVED FROM 2-AZETIDINONE AND A PREPARATION METHOD
WO2008017381A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
CN101535249A (en) * 2006-11-02 2009-09-16 塞诺菲-安万特德国有限公司 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties
DE102007002260A1 (en) 2007-01-16 2008-07-31 Sanofi-Aventis Use of substituted pyranonic acid derivatives for the preparation of medicaments for the treatment of the metabolic syndrome
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
DE102007054497B3 (en) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh New crystalline hydrate form of dodecanedioic acid 4-((2S,3R)-3-((S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl)-2-(4-methoxy-phenyl)-4-oxo-azetidin-1-yl)-benzylamide ((2S,3R,4R,5R)-pentahydroxy-hexyl)-amide useful e.g. to treat hyperlipidemia
AR072707A1 (en) 2008-07-09 2010-09-15 Sanofi Aventis HETEROCICLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION, DRUGS THAT UNDERSTAND THESE COMPOUNDS AND THE USE OF THEM
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
WO2010100255A1 (en) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
CN101993403B (en) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 Azetidinone compound and medical applications thereof
WO2011023754A1 (en) 2009-08-26 2011-03-03 Sanofi-Aventis Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683704B1 (en) 2011-03-08 2014-12-17 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656624A (en) * 1994-12-21 1997-08-12 Schering Corporation 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
WO1997016455A1 (en) * 1995-10-31 1997-05-09 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents
DE10042447A1 (en) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Vertebrate intestinal protein that absorbs cholesterol and use of this protein to identify inhibitors of intestinal cholesterol transport

Also Published As

Publication number Publication date
IL165791A0 (en) 2006-01-15
ZA200409381B (en) 2006-05-31
CA2490109A1 (en) 2003-12-31
MY135850A (en) 2008-07-31
AR039689A1 (en) 2005-03-09
MXPA04012236A (en) 2005-02-25
HRP20041203A2 (en) 2005-06-30
TW200404774A (en) 2004-04-01
ECSP045498A (en) 2005-03-10
NZ537304A (en) 2005-10-28
CN1662493A (en) 2005-08-31
PA8576001A1 (en) 2004-02-07
DE10227506A1 (en) 2004-01-08
WO2004000804A1 (en) 2003-12-31
JP2005533072A (en) 2005-11-04
AU2003242616B2 (en) 2008-12-11
EP1517892B1 (en) 2010-08-25
OA12868A (en) 2006-09-15
RU2315754C2 (en) 2008-01-27
PL372690A1 (en) 2005-07-25
DE50313017D1 (en) 2010-10-07
BR0311940A (en) 2005-04-05
HN2003000183A (en) 2003-08-01
SV2004001549A (en) 2004-03-19
TNSN04255A1 (en) 2007-03-12
RS108504A (en) 2007-02-05
AU2003242616A1 (en) 2004-01-06
PE20040577A1 (en) 2004-10-11
ATE478842T1 (en) 2010-09-15
UY27851A1 (en) 2003-12-31
MA27252A1 (en) 2005-03-01
RU2005101091A (en) 2005-07-10
EP1517892A1 (en) 2005-03-30

Similar Documents

Publication Publication Date Title
NO20050073L (en) Ring-substituted diphenyllazetidinones, their preparation, their use, and drugs containing the compounds
NO324227B1 (en) Cyclopropyl-fused pyrrolidine-based compounds, pharmaceutical compositions and combinations containing them as well as the use thereof for the manufacture of medicaments for the treatment of diseases
GB9914486D0 (en) Medicaments
NO20051695L (en) Novel spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
SE9904738D0 (en) Novel compounds
DE50311898D1 (en) FREDERICAMYCIN DERIVATIVES AS A MEDICAMENT FOR TUMOR TREATMENT
SE9904505D0 (en) Novel compounds
GB0111523D0 (en) Chemical compounds
DE60030741D1 (en) CHINAZOLINE COMPOUNDS AS A REMEDY
NO20062335L (en) New diazaspiroalkanes and their use in the treatment of CCR8 mediated diseases
MXPA04004674A (en) Cannabinoid receptor ligands.
NO20052802L (en) Pyrrolopyrimidinderivativer
NO20052883L (en) New drugs for the treatment of chronic obstructive airway disease.
NO20070576L (en) New hydantion derivatives for the treatment of obstructive airway diseases.
SE9903544D0 (en) Novel compounds
AP9701041A0 (en) Pyridylpyrrole compounds.
IL176171A0 (en) N-aryl piperidine substituted biphenylcarboxamides
NO20070570L (en) Compounds.
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
ATE236147T1 (en) DERIVATIVES OF FLAVONES, XANTHONES AND CUMARINES
NO20020282D0 (en) New diphenylpiperidine derivative
MY136632A (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
NO20044531L (en) Imidazolinylmethyl-aralkylsulfonamides, compositions comprising such, processes for the preparation thereof, such compounds as medicaments and the use of such compounds for the manufacture of medicaments for the treatment of disease
EE200200088A (en) Use of bis-sulfonamides in the manufacture of a medicament for the prevention or treatment of hyperlipidemia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application